Literature DB >> 6981353

The expression of surface antigen Leu 1 by ocular adnexal lymphoid neoplasms.

D M Knowles, F A Jakobiec, C Y Wang.   

Abstract

Leu 1 is a surface membrane antigen expressed by benign systemic T cells, most cases of B-cell-derived chronic lymphocytic leukemia, and approximately one half of the systemic B-cell lymphomas. Benign systemic B cells are Leu 1-. Our studies showed that the percentage of Leu 1+ cells was essentially the same as the percentage of OKT3+E+ (T) cells in six ocular adnexal pseudolymphomas, strongly suggesting that the benign B cells in these lesions were similarly Leu 1-. These studies also showed that malignant B cells in six of 15 (40%) ocular B-cell lymphomas were Leu 1+. Thus, the expression of Leu 1 by some malignant ocular adnexal B cells but not by benign ocular adnexal B cells appears to be analogous to the situation for lymph nodal and other systemic B cells. Although the explanation for the existence of this shared determinant is unknown, Leu 1 expression may possess clinical and diagnostic significance as a marker of neoplastic B cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981353     DOI: 10.1016/0002-9394(82)90082-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Molecular-genetic analysis of ocular adnexal benign lymphoid hyperplasias by a two-step polymerase-chain-reaction.

Authors:  Y Takano; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  An overview of ocular adnexal lymphoid tumors.

Authors:  F A Jakobiec; D M Knowles
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Gadolinium enhanced magnetic resonance imaging in the diagnosis of anterior visual pathway meningiomas.

Authors:  M G Alper; J L Sherman
Journal:  Trans Am Ophthalmol Soc       Date:  1989

4.  Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.

Authors:  B F Burns; R A Warnke; R S Doggett; R V Rouse
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.